<DOC>
	<DOCNO>NCT00421694</DOCNO>
	<brief_summary>Following radical prostatectomy ( RP ) , 20 % 40 % patient prostate cancer ( PCa ) exhibit pathological parameter associate high risk disease recurrence . The rationale NHT base theory androgen ablation induces PCa apoptosis induces regression primary tumor bulk RP . However use NHT prior RP highly controversial . In spite unenthusiastic result , relative short time treatment use different drug utilized trial might still make regimen attractive term drug relate side effect effectiveness . In regard , Bicalutamide present unique characteristic since work differently respect anti-hormonal agent interfere genotropic non-genotropic mechanism androgen receptor</brief_summary>
	<brief_title>Positive Surgical Margins Rate EGFR Family Members Expression Prostate Cancer Treated With Bicalutamide</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>Patients cT2T3a prostate cancer Men &gt; 75 year Men &lt; 18 year Prior hormonal therapy Prior radiation chemotherapy Prior investigational agent Life expectancy &gt; 10 year Prior malignancy within last five year Any serious medical psychiatric condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>